Venous thromboembolisms and stroke risk in patients with atrial fibrillation: a nationwide cohort study
Authors:
- Eero JalliEJEero Jalli
- Jussi JaakkolaJJJussi Jaakkola
- Ville LangénVLVille Langén
- K E Juhani AiraksinenKAK E Juhani Airaksinen
- Olli HalminenOHOlli Halminen
- Jukka PutaalaJPJukka Putaala
- Pirjo MustonenPMPirjo Mustonen
- Jari HaukkaJHJari Haukka
- Juha HartikainenJHJuha Hartikainen
- Miika LinnaMLMiika Linna
- Elis KoukiEKElis Kouki
- Mika LehtoMLMika Lehto
Open Access
- 29 July 2025
- journal article
- Published by Oxford University Press (OUP) in EP Europace
- Vol. 27 (8)
Abstract
Aims: Little is known about the association of venous thromboembolisms (VTEs) on the risk of ischaemic stroke (IS) in patients with atrial fibrillation (AF). Nevertheless, both pulmonary embolism (PE) and deep venous thromboembolism (DVT) are often included in the calculation of the CHA2DS2-VASc score, which is used for stroke risk stratification. Therefore, we conducted this nationwide retrospective cohort study to evaluate whether a history of VTE is associated with an increased risk of IS in patients with AF. Methods and results: The Finnish AntiCoagulation in Atrial Fibrillation (FinACAF) registry-linkage study includes all patients in Finland with incident AF from 2007 to 2018. The IS rates and rate ratios were computed for patients with and without a history of VTE. We identified 271 500 patients with new-onset AF, of whom 4.6% had prior VTE, while 1.9% had a history of PE and 3.1% a history of DVT. The crude incidence of IS was slightly higher in patients with a history of VTE compared to patients without a history of VTE, but after adjusting for baseline factors, VTE was not associated with the rate of IS [adjusted incidence rate ratio with 95% confidence interval for any VTE 1.05 (0.98–1.13), for PE 1.01 (0.91–1.13), and for DVT 1.09 (1.00–1.18)]. There was no temporal change in these associations during the study period. Conclusion: A history of VTEs was not associated with an increased risk of IS, suggesting that they do not need to be considered in the stroke risk stratification of patients with AF.Keywords
Funding Information
- Aarne Koskelo Foundation
- Finnish Foundation for Cardiovascular Research
- Helsinki and Uusimaa Hospital District research fund (TYH2019309)
This publication has 29 references indexed in Scilit:
- Acute Pulmonary Embolism in a National Danish Cohort: Increasing Incidence and Decreasing MortalityThrombosis and Haemostasis, 2018
- Benefit of Anticoagulation Unlikely in Patients With Atrial Fibrillation and a CHA2DS2-VASc Score of 1JACC, 2015
- Thrombosis: A Major Contributor to Global Disease BurdenSeminars in Thrombosis and Hemostasis, 2014
- Trends in hospital admissions for pulmonary embolism in Spain from 2002 to 2011European Respiratory Journal, 2014
- Atrial Fibrillation, Stroke Risk, and Warfarin Therapy RevisitedStroke, 2013
- Quality of the Finnish Hospital Discharge Register: A systematic reviewScandinavian Journal of Public Health, 2012
- Evaluation of risk stratification schemes for ischaemic stroke and bleeding in 182 678 patients with atrial fibrillation: the Swedish Atrial Fibrillation cohort studyEuropean Heart Journal, 2012
- Time Trends in Pulmonary Embolism in the United StatesArchives of internal medicine (1960), 2011
- Validation of risk stratification schemes for predicting stroke and thromboembolism in patients with atrial fibrillation: nationwide cohort studyBMJ, 2011
- Refining Clinical Risk Stratification for Predicting Stroke and Thromboembolism in Atrial Fibrillation Using a Novel Risk Factor-Based ApproachChest, 2010